Diabetes Care Devices Market-GCC
Market Statistics
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 787.52 Million
Market Size in 2033: USD 1614.05 Million
Market Growth Rate (CAGR) 2025-2033: 7.70%
According to IMARC Group's report titled "GCC Diabetes Care Devices Market Report and Forecast 2025-2033," the market reached USD 787.52 million in 2024. Looking forward, IMARC Group expects the market to reach USD 1614.05 million by 2033, exhibiting a growth rate (CAGR) of 7.70% during 2025-2033.
GCC Diabetes Care Devices Market Trends and Drivers:
- High prevalence of diabetes driven by lifestyle factors, obesity, and genetics is a major market driver.
- Sophisticated diabetes management devices such as blood glucose meters, insulin pumps, and CGM systems are propelling market growth.
- Government initiatives to establish robust healthcare infrastructure and raise awareness about diabetes care further stimulate the industry.
- Increased use of digital health solutions and telemedicine services in the GCC enhances access to diabetes care products and improves patient monitoring.
- Rapid adoption of advanced technology is leading to the development of hassle-free, connected diabetes care devices.
- Bluetooth and app connectivity in smart devices enable real-time data sharing with healthcare professionals for personalized treatment plans.
- Artificial pancreas devices and non-invasive blood glucose monitoring systems are gradually gaining acceptance for their convenience and comfort.
- There is a growing trend toward preventive medicine, with increased demand for wearables that support long-term monitoring and early detection of glucose deficiencies.
- The proliferation of e-commerce platforms has expanded the variety and availability of diabetes care products.
- Manufacturers are increasingly implementing green materials and eco-friendly packaging solutions to drive sustainability in the market.
Download sample copy of the Report: https://www.imarcgroup.com/gcc-diabetes-care-devices-market/requestsample
GCC Diabetes Care Devices Industry Segmentation:
The report has segmented the market into the following categories:
Analysis by Type:
- Blood Glucose Monitoring (BGM) Devices
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
Analysis by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Diabetes Clinics/ Centers
- Online Pharmacies
- Others
Analysis by End User:
- Hospitals
- Home Care
- Diagnostic Centers
- Ambulatory Surgery Centers
Country Analysis:
- Saudi Arabia
- UAE
- Qatar
- Kuwait
- Oman
- Bahrain
Request for customization: https://www.imarcgroup.com/request?type=report&id=26098&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players. Few Key Players are:
- Dexcom Inc.
- Insulet Corporation
- Medtronic PLC
- Novo Nordisk A/S
- Ascensia Diabetes Care
- Bionime Corporation
- Becton, Dickinson and Company
- Abbott Diabetes Care
- Eli Lilly
- Sanofi
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments